Selected article for: "expression analysis and relative expression"

Author: Sun, Shihui; Jiang, Yuting; Wang, Renxi; Liu, Chenfeng; Liu, Xiaoling; Song, Nianping; Guo, Yan; Guo, Renfeng; Du, Lanying; Jiang, Shibo; Li, Yan; Qiu, Zewu; Zhao, Guangyu; Zhou, Yusen
Title: Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application*
  • Document date: 2018_4_13
  • ID: 6ztwho9k_13
    Snippet: The blocking efficiency of IFX-1 was tested in a CD11b assay (11) . Damage to the lung tissues was evaluated as previously described (28) . The concentrations of C5a, C3a, and C5b-9 in plasma were measured using human enzyme-linked immunosorbent assay (ELISA) kits (BD Biosciences, San Jose, CA). Measurements of inflammatory cytokines in serum were performed using ELISA kits (U-CyTech Biosciences, Utrecht, The Netherlands; Uscn Life Sciences, Hous.....
    Document: The blocking efficiency of IFX-1 was tested in a CD11b assay (11) . Damage to the lung tissues was evaluated as previously described (28) . The concentrations of C5a, C3a, and C5b-9 in plasma were measured using human enzyme-linked immunosorbent assay (ELISA) kits (BD Biosciences, San Jose, CA). Measurements of inflammatory cytokines in serum were performed using ELISA kits (U-CyTech Biosciences, Utrecht, The Netherlands; Uscn Life Sciences, Houston, TX; or eBioscience, Austria, respectively). The analysis of C3c deposition and expression of C3a receptor (C3aR), C5a receptor (C5aR), CD68, myeloperoxidase, surfactant protein A (SP-A), and vascular endothelial-cadherin were detected by immunohistochemistry staining. The relative expression of VE-cadherin was analyzed using the 2 -△△CT method (29) . For detailed information, see Supplemental Material (Supplemental Digital Content 1, http://links.lww.com/CCM/D159).

    Search related documents:
    Co phrase search for related documents
    • CT method and inflammatory cytokine: 1
    • CT method and lung tissue: 1, 2, 3, 4, 5, 6, 7
    • CT method and lung tissue damage: 1
    • CT method and relative expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • detailed information and human enzyme: 1
    • detailed information and inflammatory cytokine: 1
    • detailed information and lung tissue: 1, 2
    • detailed information and surfactant protein: 1
    • ELISA kit and human enzyme: 1, 2
    • ELISA kit and immunohistochemistry staining: 1
    • ELISA kit and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ELISA kit and immunosorbent assay ELISA kit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • ELISA kit and inflammatory cytokine: 1
    • ELISA kit and lung tissue: 1, 2
    • ELISA kit and lung tissue damage: 1
    • human enzyme and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • human enzyme and lung tissue damage: 1, 2
    • human enzyme and relative expression: 1
    • human enzyme and surfactant protein: 1